

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.93122804 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.93122804 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.53253996 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53253996 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.42582476 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.96894358 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.92178516 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.92178516 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.92178516 |
| 10 | complement activation, alternative pathway (GO:0006957) | 5.89715884 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.88571610 |
| 12 | regulation of protein activation cascade (GO:2000257) | 5.65025603 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.48932139 |
| 14 | urea metabolic process (GO:0019627) | 5.48381288 |
| 15 | urea cycle (GO:0000050) | 5.48381288 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.47425000 |
| 17 | angiotensin maturation (GO:0002003) | 5.47007225 |
| 18 | regulation of complement activation (GO:0030449) | 5.38568521 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.37689502 |
| 20 | cysteine metabolic process (GO:0006534) | 5.31934760 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.21995127 |
| 22 | protein carboxylation (GO:0018214) | 5.21995127 |
| 23 | homocysteine metabolic process (GO:0050667) | 5.18950954 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.14679045 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.05593147 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.03916905 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.00403344 |
| 28 | bile acid metabolic process (GO:0008206) | 4.95330785 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.88052207 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.84270694 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.83599356 |
| 32 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.77019142 |
| 33 | virion attachment to host cell (GO:0019062) | 4.76516387 |
| 34 | adhesion of symbiont to host cell (GO:0044650) | 4.76516387 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.72307432 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 4.67218556 |
| 37 | cellular glucuronidation (GO:0052695) | 4.63963009 |
| 38 | acylglycerol homeostasis (GO:0055090) | 4.59997773 |
| 39 | triglyceride homeostasis (GO:0070328) | 4.59997773 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55280206 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.51158669 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.48243495 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.44553145 |
| 44 | transcytosis (GO:0045056) | 4.44140629 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.42777475 |
| 46 | lysine catabolic process (GO:0006554) | 4.38102856 |
| 47 | lysine metabolic process (GO:0006553) | 4.38102856 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.35892693 |
| 49 | phospholipid efflux (GO:0033700) | 4.28398568 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 4.28166814 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.27736298 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27736298 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.27736298 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.22397022 |
| 55 | uronic acid metabolic process (GO:0006063) | 4.20926715 |
| 56 | glucuronate metabolic process (GO:0019585) | 4.20926715 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.20574732 |
| 58 | amine catabolic process (GO:0009310) | 4.19607376 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.19607376 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 4.16544786 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.15051491 |
| 62 | phospholipid homeostasis (GO:0055091) | 4.14193826 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 4.13768981 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.13297094 |
| 65 | glycine metabolic process (GO:0006544) | 4.09789086 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.07029890 |
| 67 | negative regulation of sterol transport (GO:0032372) | 4.07029890 |
| 68 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.00955738 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.00567436 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.99411878 |
| 71 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99279987 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.99043441 |
| 73 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95958967 |
| 74 | cholesterol efflux (GO:0033344) | 3.94666918 |
| 75 | glutamate metabolic process (GO:0006536) | 3.92575924 |
| 76 | cholesterol homeostasis (GO:0042632) | 3.89926801 |
| 77 | fibrinolysis (GO:0042730) | 3.88440949 |
| 78 | sterol homeostasis (GO:0055092) | 3.87891174 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 3.86801145 |
| 80 | complement activation (GO:0006956) | 3.83908977 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 3.82885646 |
| 82 | epoxygenase P450 pathway (GO:0019373) | 3.81683472 |
| 83 | eosinophil chemotaxis (GO:0048245) | 3.81541365 |
| 84 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.79851511 |
| 85 | heme transport (GO:0015886) | 3.78053981 |
| 86 | adhesion of symbiont to host (GO:0044406) | 3.78020281 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.75367899 |
| 88 | protein activation cascade (GO:0072376) | 3.74865401 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73236955 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.71900499 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.71380026 |
| 92 | negative regulation of protein activation cascade (GO:2000258) | 3.71078695 |
| 93 | sphingolipid catabolic process (GO:0030149) | 3.69980067 |
| 94 | glycolipid catabolic process (GO:0019377) | 3.68233039 |
| 95 | regulation of guanylate cyclase activity (GO:0031282) | 3.67815107 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 3.67650128 |
| 97 | cytochrome complex assembly (GO:0017004) | 3.66374759 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.65993536 |
| 99 | imidazole-containing compound metabolic process (GO:0052803) | 3.65710557 |
| 100 | vitamin biosynthetic process (GO:0009110) | 3.64839415 |
| 101 | response to nitrosative stress (GO:0051409) | 3.61139174 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.60166355 |
| 103 | organic acid catabolic process (GO:0016054) | 3.60166355 |
| 104 | membrane lipid catabolic process (GO:0046466) | 3.57292769 |
| 105 | platelet dense granule organization (GO:0060155) | 3.56500399 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51960801 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.50429343 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49288078 |
| 109 | ceramide catabolic process (GO:0046514) | 3.48494441 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.47509004 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47488354 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47488354 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 3.46519538 |
| 114 | fatty acid oxidation (GO:0019395) | 3.44386249 |
| 115 | flavonoid metabolic process (GO:0009812) | 3.43722605 |
| 116 | cofactor catabolic process (GO:0051187) | 3.43411636 |
| 117 | negative regulation of lipase activity (GO:0060192) | 3.43048867 |
| 118 | NAD biosynthetic process (GO:0009435) | 3.42722782 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.42590638 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.42485592 |
| 121 | arginine metabolic process (GO:0006525) | 3.42480299 |
| 122 | respiratory chain complex IV assembly (GO:0008535) | 3.34787423 |
| 123 | eosinophil migration (GO:0072677) | 3.34361475 |
| 124 | positive regulation of heat generation (GO:0031652) | 3.27987999 |
| 125 | vitamin D metabolic process (GO:0042359) | 3.27638757 |
| 126 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.24370233 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21599463 |
| 128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17464292 |
| 129 | negative regulation of telomere maintenance (GO:0032205) | 3.17157828 |
| 130 | positive regulation of prostaglandin secretion (GO:0032308) | 3.16898951 |
| 131 | L-ascorbic acid metabolic process (GO:0019852) | 3.14035941 |
| 132 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.10308249 |
| 133 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.02940718 |
| 134 | negative regulation of telomerase activity (GO:0051974) | 2.99714298 |
| 135 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.99447338 |
| 136 | vitamin transport (GO:0051180) | 2.96538379 |
| 137 | DNA damage response, detection of DNA damage (GO:0042769) | 2.96076016 |
| 138 | drug catabolic process (GO:0042737) | 2.94772758 |
| 139 | fat-soluble vitamin metabolic process (GO:0006775) | 2.89817311 |
| 140 | regulation of fever generation (GO:0031620) | 2.89128735 |
| 141 | cyclooxygenase pathway (GO:0019371) | 2.86985953 |
| 142 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85911381 |
| 143 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85125685 |
| 144 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.84460298 |
| 145 | response to pH (GO:0009268) | 2.80879328 |
| 146 | regulation of cellular extravasation (GO:0002691) | 2.78376984 |
| 147 | amino sugar catabolic process (GO:0046348) | 2.77660084 |
| 148 | folic acid transport (GO:0015884) | 2.76794056 |
| 149 | xenobiotic catabolic process (GO:0042178) | 2.76256180 |
| 150 | monocyte chemotaxis (GO:0002548) | 2.74023021 |
| 151 | exogenous drug catabolic process (GO:0042738) | 2.73650755 |
| 152 | positive regulation of icosanoid secretion (GO:0032305) | 2.72322057 |
| 153 | regulation of heat generation (GO:0031650) | 2.71373162 |
| 154 | response to hydroperoxide (GO:0033194) | 2.71016462 |
| 155 | transepithelial transport (GO:0070633) | 2.69208610 |
| 156 | glutathione derivative metabolic process (GO:1901685) | 2.69138060 |
| 157 | glutathione derivative biosynthetic process (GO:1901687) | 2.69138060 |
| 158 | protein complex biogenesis (GO:0070271) | 2.69016927 |
| 159 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68478370 |
| 160 | ATP synthesis coupled proton transport (GO:0015986) | 2.68478370 |
| 161 | respiratory electron transport chain (GO:0022904) | 2.66307462 |
| 162 | atrial cardiac muscle cell action potential (GO:0086014) | 2.65928345 |
| 163 | positive regulation of fatty acid transport (GO:2000193) | 2.65548931 |
| 164 | drug metabolic process (GO:0017144) | 2.65181324 |
| 165 | response to acidic pH (GO:0010447) | 2.64040896 |
| 166 | T-helper 1 type immune response (GO:0042088) | 2.62835091 |
| 167 | electron transport chain (GO:0022900) | 2.61320744 |
| 168 | negative regulation of interleukin-12 production (GO:0032695) | 2.60775258 |
| 169 | positive regulation of respiratory burst (GO:0060267) | 2.59435304 |
| 170 | regulation of antigen processing and presentation (GO:0002577) | 2.58891546 |
| 171 | regulation of prostaglandin secretion (GO:0032306) | 2.58779981 |
| 172 | cellular response to pH (GO:0071467) | 2.57563986 |
| 173 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.57043404 |
| 174 | regulation of cGMP biosynthetic process (GO:0030826) | 2.56673204 |
| 175 | myeloid dendritic cell differentiation (GO:0043011) | 2.55981983 |
| 176 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.55788439 |
| 177 | protein neddylation (GO:0045116) | 2.54532644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.70311459 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.55764024 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54210731 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.30989123 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85221284 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.65767760 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.43895055 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.12552340 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67990495 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.50798123 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.92950021 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.88528162 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.85402139 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.76317311 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67599958 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35625080 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.31890823 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16693939 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15900966 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15342243 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.13894861 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.05596449 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7798799 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96268342 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87130386 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81927462 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.80908251 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76231213 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75478349 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72776903 |
| 31 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.72720392 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.68988269 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68701756 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.68211591 |
| 35 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.65055122 |
| 36 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.65055122 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63868903 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62559234 |
| 39 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.59523704 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57744772 |
| 41 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54592852 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54423866 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53645626 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52955975 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51180137 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49680062 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49600466 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49232524 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49087904 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43307205 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41897401 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38760349 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38088394 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37442852 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37107713 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36624879 |
| 57 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.35878857 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35144247 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33781699 |
| 60 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.33713680 |
| 61 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31303859 |
| 62 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.30851836 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.27768953 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27201896 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25539813 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22596391 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22452419 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19909222 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19279947 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18852745 |
| 71 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18617064 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18617064 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18253631 |
| 74 | NCOR_22424771_ChIP-Seq_293T_Human | 1.14792850 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14117669 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13716196 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12753986 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12753986 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12613947 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12609852 |
| 81 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.12007434 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08960940 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07490669 |
| 84 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06512812 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06464522 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05669611 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04666475 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04138434 |
| 89 | NFYA_21822215_ChIP-Seq_K562_Human | 1.03709481 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03087606 |
| 91 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03042036 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02175066 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01553894 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00943882 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00041880 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99193249 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98921594 |
| 98 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98858086 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97773486 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97281846 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96738221 |
| 102 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94209387 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94150487 |
| 104 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93754263 |
| 105 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.93505804 |
| 106 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93172058 |
| 107 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92699818 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90477777 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90477777 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88390519 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83991780 |
| 112 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.83600354 |
| 113 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.83600354 |
| 114 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.83600354 |
| 115 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82030403 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81315193 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80653921 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.79737758 |
| 119 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79603312 |
| 120 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78671228 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77879977 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.77666840 |
| 123 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76016398 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75710251 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74395572 |
| 126 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.74072811 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73690679 |
| 128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.73501984 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72842233 |
| 130 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72552831 |
| 131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.71518877 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71273544 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.70540110 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70300259 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69640507 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.69451940 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69263168 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.68389976 |
| 139 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67298483 |
| 140 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.64902086 |
| 141 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63138033 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63135756 |
| 143 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63049768 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62424355 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62296480 |
| 146 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61244346 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60443339 |
| 148 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.60140069 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59201496 |
| 150 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59162621 |
| 151 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.58005920 |
| 152 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57840630 |
| 153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.57623875 |
| 154 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.56591485 |
| 155 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.56363396 |
| 156 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55571025 |
| 157 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.54270020 |
| 158 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54158504 |
| 159 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.52078102 |
| 160 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52063624 |
| 161 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50479786 |
| 162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50171416 |
| 163 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.49915986 |
| 164 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48664622 |
| 165 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48326502 |
| 166 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47824414 |
| 167 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.47352515 |
| 168 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.47340492 |
| 169 | CJUN_26792858_Chip-Seq_BT549_Human | 0.46214341 |
| 170 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45763376 |
| 171 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.44762336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.36534310 |
| 2 | MP0005360_urolithiasis | 6.84782346 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30587010 |
| 4 | MP0005365_abnormal_bile_salt | 5.71283151 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.28681328 |
| 6 | MP0003252_abnormal_bile_duct | 4.01771101 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.44372984 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.39310427 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.35129918 |
| 10 | MP0005083_abnormal_biliary_tract | 3.33527591 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.76538867 |
| 12 | MP0003195_calcinosis | 2.58337098 |
| 13 | MP0004510_myositis | 2.57293738 |
| 14 | MP0005332_abnormal_amino_acid | 2.55063391 |
| 15 | MP0009840_abnormal_foam_cell | 2.54766469 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.44710192 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.42438104 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.24985816 |
| 19 | MP0006054_spinal_hemorrhage | 2.14957860 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.14916863 |
| 21 | MP0000609_abnormal_liver_physiology | 2.12226390 |
| 22 | MP0004147_increased_porphyrin_level | 2.10144674 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.01369862 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.94355510 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.94243386 |
| 26 | MP0005670_abnormal_white_adipose | 1.87824624 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.85642070 |
| 28 | MP0003303_peritoneal_inflammation | 1.79361857 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.65979149 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.63886191 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.61301965 |
| 32 | MP0009785_altered_susceptibility_to | 1.57603071 |
| 33 | MP0003868_abnormal_feces_composition | 1.51164085 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.50706016 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.45285074 |
| 36 | MP0008004_abnormal_stomach_pH | 1.41489855 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.40800687 |
| 38 | MP0005387_immune_system_phenotype | 1.40585729 |
| 39 | MP0001790_abnormal_immune_system | 1.40585729 |
| 40 | MP0003011_delayed_dark_adaptation | 1.39725630 |
| 41 | MP0003075_altered_response_to | 1.39653203 |
| 42 | MP0000343_altered_response_to | 1.37521842 |
| 43 | MP0005671_abnormal_response_to | 1.35171142 |
| 44 | MP0003718_maternal_effect | 1.29027490 |
| 45 | MP0001764_abnormal_homeostasis | 1.28982087 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.28235645 |
| 47 | MP0003690_abnormal_glial_cell | 1.27784844 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27654731 |
| 49 | MP0001485_abnormal_pinna_reflex | 1.25913600 |
| 50 | MP0005310_abnormal_salivary_gland | 1.25279006 |
| 51 | MP0003186_abnormal_redox_activity | 1.25083851 |
| 52 | MP0005166_decreased_susceptibility_to | 1.19454005 |
| 53 | MP0000598_abnormal_liver_morphology | 1.17184489 |
| 54 | MP0009697_abnormal_copulation | 1.16844915 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.15769377 |
| 56 | MP0005025_abnormal_response_to | 1.13644025 |
| 57 | MP0001853_heart_inflammation | 1.13386918 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.13182162 |
| 59 | MP0002419_abnormal_innate_immunity | 1.12173319 |
| 60 | MP0001663_abnormal_digestive_system | 1.07845283 |
| 61 | MP0001542_abnormal_bone_strength | 1.06842837 |
| 62 | MP0009763_increased_sensitivity_to | 1.05530194 |
| 63 | MP0005647_abnormal_sex_gland | 1.05331416 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.03682364 |
| 65 | MP0004130_abnormal_muscle_cell | 1.03497789 |
| 66 | MP0000538_abnormal_urinary_bladder | 1.03223706 |
| 67 | MP0005451_abnormal_body_composition | 1.02606905 |
| 68 | MP0009764_decreased_sensitivity_to | 1.01859781 |
| 69 | MP0010307_abnormal_tumor_latency | 0.99168907 |
| 70 | MP0003724_increased_susceptibility_to | 0.97928513 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.95485013 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.94939783 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.94075712 |
| 74 | MP0005275_abnormal_skin_tensile | 0.92614311 |
| 75 | MP0002254_reproductive_system_inflammat | 0.91780242 |
| 76 | MP0002090_abnormal_vision | 0.91474589 |
| 77 | MP0001873_stomach_inflammation | 0.89518693 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.88153631 |
| 79 | MP0009053_abnormal_anal_canal | 0.87259653 |
| 80 | MP0005503_abnormal_tendon_morphology | 0.87051179 |
| 81 | MP0005000_abnormal_immune_tolerance | 0.87049585 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 0.86326777 |
| 83 | MP0003941_abnormal_skin_development | 0.86015118 |
| 84 | MP0000490_abnormal_crypts_of | 0.85793097 |
| 85 | MP0005334_abnormal_fat_pad | 0.85567854 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.84602830 |
| 87 | MP0008469_abnormal_protein_level | 0.83834789 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.82618881 |
| 89 | MP0005023_abnormal_wound_healing | 0.82259564 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.81848810 |
| 91 | MP0004883_abnormal_blood_vessel | 0.81567113 |
| 92 | MP0002723_abnormal_immune_serum | 0.81486265 |
| 93 | MP0004133_heterotaxia | 0.80464478 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.79631875 |
| 95 | MP0001188_hyperpigmentation | 0.79492274 |
| 96 | MP0002971_abnormal_brown_adipose | 0.79369318 |
| 97 | MP0002452_abnormal_antigen_presenting | 0.79053942 |
| 98 | MP0004742_abnormal_vestibular_system | 0.78473170 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.76987923 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.76427036 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.76401066 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.75611665 |
| 103 | MP0002060_abnormal_skin_morphology | 0.74606783 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.74605680 |
| 105 | MP0001661_extended_life_span | 0.72974039 |
| 106 | MP0003136_yellow_coat_color | 0.72064843 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.70951767 |
| 108 | MP0000427_abnormal_hair_cycle | 0.70696108 |
| 109 | MP0000604_amyloidosis | 0.70502867 |
| 110 | MP0001243_abnormal_dermal_layer | 0.70450751 |
| 111 | MP0003448_altered_tumor_morphology | 0.67544404 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.67223675 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.66536606 |
| 114 | MP0000249_abnormal_blood_vessel | 0.66451721 |
| 115 | MP0005410_abnormal_fertilization | 0.66264110 |
| 116 | MP0006072_abnormal_retinal_apoptosis | 0.66146043 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.66044118 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.65021496 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.64376826 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.64121303 |
| 121 | MP0002928_abnormal_bile_duct | 0.63695694 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.61913095 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.61383165 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.60951982 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.60837337 |
| 126 | MP0009115_abnormal_fat_cell | 0.60417624 |
| 127 | MP0001915_intracranial_hemorrhage | 0.59602143 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.58851887 |
| 129 | MP0003436_decreased_susceptibility_to | 0.58707971 |
| 130 | MP0005164_abnormal_response_to | 0.56730832 |
| 131 | MP0006082_CNS_inflammation | 0.56401958 |
| 132 | MP0005535_abnormal_body_temperature | 0.53507344 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.51770858 |
| 134 | MP0001879_abnormal_lymphatic_vessel | 0.51744567 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.50510038 |
| 136 | MP0005266_abnormal_metabolism | 0.50390175 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.48676296 |
| 138 | MP0005375_adipose_tissue_phenotype | 0.48082205 |
| 139 | MP0001756_abnormal_urination | 0.47217580 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.46361523 |
| 141 | MP0005408_hypopigmentation | 0.45984337 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.44437182 |
| 143 | MP0008873_increased_physiological_sensi | 0.43891430 |
| 144 | MP0005395_other_phenotype | 0.43455447 |
| 145 | MP0001119_abnormal_female_reproductive | 0.43273523 |
| 146 | MP0000579_abnormal_nail_morphology | 0.43199076 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.41913377 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.41395452 |
| 149 | MP0003453_abnormal_keratinocyte_physiol | 0.41125445 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.40736385 |
| 151 | MP0002970_abnormal_white_adipose | 0.40022564 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.39931597 |
| 153 | MP0002168_other_aberrant_phenotype | 0.38295422 |
| 154 | MP0004381_abnormal_hair_follicle | 0.38198642 |
| 155 | MP0005448_abnormal_energy_balance | 0.36575246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.76354637 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.76145850 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.28060292 |
| 4 | Complement deficiency (HP:0004431) | 6.20965586 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.08031082 |
| 6 | Xanthomatosis (HP:0000991) | 5.91770958 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.45914451 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.44257054 |
| 9 | Disinhibition (HP:0000734) | 5.15791950 |
| 10 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.97169312 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.93005250 |
| 12 | Epidermoid cyst (HP:0200040) | 4.72236311 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.69983528 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.69983528 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.69983528 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.69535513 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.62898845 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.55852791 |
| 19 | Abnormality of complement system (HP:0005339) | 4.55828263 |
| 20 | Hyperglycinuria (HP:0003108) | 4.38276524 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27692882 |
| 22 | Joint hemorrhage (HP:0005261) | 4.26593220 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 4.25025601 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06894743 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01914392 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 4.01914392 |
| 27 | Agnosia (HP:0010524) | 3.97797677 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.93879416 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93663913 |
| 30 | Hyperammonemia (HP:0001987) | 3.93628804 |
| 31 | Hyperglycinemia (HP:0002154) | 3.93308619 |
| 32 | Fat malabsorption (HP:0002630) | 3.89345802 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.78914326 |
| 34 | Glomerulonephritis (HP:0000099) | 3.77277480 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.70507944 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.70141970 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.63876741 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.60421525 |
| 39 | Ketosis (HP:0001946) | 3.53093649 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.52978793 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46915969 |
| 42 | Mutism (HP:0002300) | 3.44052468 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.43363585 |
| 44 | Myocardial infarction (HP:0001658) | 3.42680694 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41706320 |
| 46 | Inappropriate behavior (HP:0000719) | 3.38172811 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37640577 |
| 48 | Hydroxyprolinuria (HP:0003080) | 3.28127715 |
| 49 | Abnormality of proline metabolism (HP:0010907) | 3.28127715 |
| 50 | Delayed CNS myelination (HP:0002188) | 3.14924066 |
| 51 | Spontaneous abortion (HP:0005268) | 3.10116241 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 3.09407366 |
| 53 | Loss of speech (HP:0002371) | 3.08564652 |
| 54 | Skin nodule (HP:0200036) | 3.07817802 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.96535477 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.96217897 |
| 57 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96194312 |
| 58 | Steatorrhea (HP:0002570) | 2.95570068 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.92047632 |
| 60 | Glycosuria (HP:0003076) | 2.85477575 |
| 61 | Abnormality of urine glucose concentration (HP:0011016) | 2.85477575 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.80737901 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.77079278 |
| 64 | Nephritis (HP:0000123) | 2.69162114 |
| 65 | Abnormality of vitamin B metabolism (HP:0004340) | 2.67364485 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.62440599 |
| 67 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.61250170 |
| 68 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.59161606 |
| 69 | Methylmalonic aciduria (HP:0012120) | 2.57903831 |
| 70 | Nuclear cataract (HP:0100018) | 2.55387300 |
| 71 | Upper motor neuron abnormality (HP:0002127) | 2.55016904 |
| 72 | Acute necrotizing encephalopathy (HP:0006965) | 2.53754903 |
| 73 | Azoospermia (HP:0000027) | 2.51533997 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.50480258 |
| 75 | Ketoacidosis (HP:0001993) | 2.47527164 |
| 76 | Mitochondrial inheritance (HP:0001427) | 2.45720647 |
| 77 | Increased CSF lactate (HP:0002490) | 2.43739062 |
| 78 | Reticulocytopenia (HP:0001896) | 2.43612486 |
| 79 | Retinal atrophy (HP:0001105) | 2.42905875 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41468258 |
| 81 | Acute encephalopathy (HP:0006846) | 2.40545877 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.39530652 |
| 83 | Metabolic acidosis (HP:0001942) | 2.38690380 |
| 84 | Esophageal varix (HP:0002040) | 2.37574422 |
| 85 | Abolished electroretinogram (ERG) (HP:0000550) | 2.31996649 |
| 86 | Polyphagia (HP:0002591) | 2.31345663 |
| 87 | Hematochezia (HP:0002573) | 2.31063421 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.29113310 |
| 89 | Gingival bleeding (HP:0000225) | 2.28444272 |
| 90 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28415503 |
| 91 | Spastic diplegia (HP:0001264) | 2.27854082 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27341369 |
| 93 | Renal Fanconi syndrome (HP:0001994) | 2.23745923 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 2.20914789 |
| 95 | Pancreatitis (HP:0001733) | 2.20294020 |
| 96 | Mitral stenosis (HP:0001718) | 2.19551265 |
| 97 | Vascular calcification (HP:0004934) | 2.19378905 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.16503628 |
| 99 | Enlarged kidneys (HP:0000105) | 2.16133812 |
| 100 | Increased hepatocellular lipid droplets (HP:0006565) | 2.14803551 |
| 101 | Metaphyseal irregularity (HP:0003025) | 2.14040239 |
| 102 | Progressive macrocephaly (HP:0004481) | 2.12448878 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.12306013 |
| 104 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10679994 |
| 105 | Abnormality of the basal ganglia (HP:0002134) | 2.10388012 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10165537 |
| 107 | Opisthotonus (HP:0002179) | 2.09603969 |
| 108 | Abnormality of vitamin metabolism (HP:0100508) | 2.07602470 |
| 109 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05761493 |
| 110 | Conjunctival telangiectasia (HP:0000524) | 2.04570942 |
| 111 | Stomatitis (HP:0010280) | 2.04006981 |
| 112 | Renal cortical cysts (HP:0000803) | 2.03594074 |
| 113 | Hyperphosphaturia (HP:0003109) | 2.02583243 |
| 114 | Menorrhagia (HP:0000132) | 2.02269186 |
| 115 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02099584 |
| 116 | Axonal loss (HP:0003447) | 2.02015581 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01613148 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.01613148 |
| 119 | Hyperuricemia (HP:0002149) | 2.00046903 |
| 120 | Increased purine levels (HP:0004368) | 2.00046903 |
| 121 | Generalized aminoaciduria (HP:0002909) | 1.99802622 |
| 122 | Macrocytic anemia (HP:0001972) | 1.99542921 |
| 123 | Acanthocytosis (HP:0001927) | 1.99276158 |
| 124 | Abnormality of macrophages (HP:0004311) | 1.98293546 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97338119 |
| 126 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96976147 |
| 127 | Hepatic necrosis (HP:0002605) | 1.96735826 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96719327 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96719327 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96719327 |
| 131 | Lethargy (HP:0001254) | 1.96031024 |
| 132 | Neonatal hypoglycemia (HP:0001998) | 1.93650141 |
| 133 | Amyloidosis (HP:0011034) | 1.92705896 |
| 134 | Gout (HP:0001997) | 1.91292476 |
| 135 | Confusion (HP:0001289) | 1.90992618 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.90986963 |
| 137 | Hyperglycemia (HP:0003074) | 1.86281213 |
| 138 | Respiratory failure (HP:0002878) | 1.86208104 |
| 139 | Nausea (HP:0002018) | 1.85968465 |
| 140 | Cerebral edema (HP:0002181) | 1.85843129 |
| 141 | Hepatocellular necrosis (HP:0001404) | 1.85264516 |
| 142 | Increased mean platelet volume (HP:0011877) | 1.83769604 |
| 143 | Multiple enchondromatosis (HP:0005701) | 1.83577550 |
| 144 | Abnormality of lateral ventricle (HP:0030047) | 1.83516247 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.83049915 |
| 146 | Thrombophlebitis (HP:0004418) | 1.82738726 |
| 147 | Rickets (HP:0002748) | 1.82229199 |
| 148 | Respiratory difficulties (HP:0002880) | 1.81769114 |
| 149 | Parakeratosis (HP:0001036) | 1.79602451 |
| 150 | Hypertriglyceridemia (HP:0002155) | 1.79557640 |
| 151 | Petechiae (HP:0000967) | 1.78389494 |
| 152 | Neonatal onset (HP:0003623) | 1.78088914 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.77212190 |
| 154 | Sensorimotor neuropathy (HP:0007141) | 1.77041376 |
| 155 | Malnutrition (HP:0004395) | 1.76508057 |
| 156 | Bone cyst (HP:0012062) | 1.76371703 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.76005893 |
| 158 | CNS demyelination (HP:0007305) | 1.75512504 |
| 159 | Dementia (HP:0000726) | 1.75226842 |
| 160 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74856874 |
| 161 | Mucopolysacchariduria (HP:0008155) | 1.74856874 |
| 162 | Irritability (HP:0000737) | 1.74818751 |
| 163 | Peripheral demyelination (HP:0011096) | 1.74119563 |
| 164 | Posterior subcapsular cataract (HP:0007787) | 1.74036987 |
| 165 | Purpura (HP:0000979) | 1.72815894 |
| 166 | Abnormality of renal resorption (HP:0011038) | 1.72492436 |
| 167 | Methylmalonic acidemia (HP:0002912) | 1.72358775 |
| 168 | Abnormal spermatogenesis (HP:0008669) | 1.71985678 |
| 169 | Abnormal gallbladder morphology (HP:0012437) | 1.71176486 |
| 170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70427173 |
| 171 | Abnormality of iron homeostasis (HP:0011031) | 1.68525251 |
| 172 | Vomiting (HP:0002013) | 1.64607785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.67082930 |
| 2 | BCKDK | 4.52296513 |
| 3 | NEK9 | 4.51377726 |
| 4 | NME2 | 4.01268112 |
| 5 | PDK2 | 3.65543096 |
| 6 | FGFR4 | 3.26860431 |
| 7 | SIK1 | 3.09260272 |
| 8 | LATS1 | 2.89688718 |
| 9 | MAP2K6 | 2.55921702 |
| 10 | TLK1 | 2.47455874 |
| 11 | EPHA3 | 2.43912041 |
| 12 | IRAK3 | 2.37906021 |
| 13 | TAOK3 | 2.31341063 |
| 14 | ADRBK2 | 2.25679428 |
| 15 | INSRR | 2.22312118 |
| 16 | GRK7 | 2.18040989 |
| 17 | ACVR1B | 2.07788293 |
| 18 | MAP4K2 | 2.05108672 |
| 19 | FRK | 2.00625290 |
| 20 | TNIK | 1.94668411 |
| 21 | NEK6 | 1.87916733 |
| 22 | STK24 | 1.81553730 |
| 23 | MKNK2 | 1.80573372 |
| 24 | MAP3K11 | 1.76718109 |
| 25 | IRAK1 | 1.76422336 |
| 26 | ERBB4 | 1.65995894 |
| 27 | CAMKK2 | 1.64452852 |
| 28 | IRAK2 | 1.57233582 |
| 29 | PDK3 | 1.52478101 |
| 30 | PDK4 | 1.52478101 |
| 31 | MAP3K14 | 1.51651035 |
| 32 | MATK | 1.49129868 |
| 33 | CDK6 | 1.47721286 |
| 34 | JAK1 | 1.46895914 |
| 35 | CAMK1D | 1.45824663 |
| 36 | TYK2 | 1.44378594 |
| 37 | DYRK3 | 1.43651452 |
| 38 | PIK3CG | 1.40804361 |
| 39 | FGFR2 | 1.38379976 |
| 40 | MAP3K5 | 1.38365970 |
| 41 | PINK1 | 1.37830151 |
| 42 | OXSR1 | 1.34575990 |
| 43 | MAPK11 | 1.31561374 |
| 44 | IKBKB | 1.29767238 |
| 45 | BLK | 1.29495099 |
| 46 | MST4 | 1.29244805 |
| 47 | MKNK1 | 1.28325810 |
| 48 | DDR2 | 1.25060219 |
| 49 | STK38L | 1.17371602 |
| 50 | PRKAA2 | 1.16889524 |
| 51 | TAOK1 | 1.15013610 |
| 52 | PRKCG | 1.13790455 |
| 53 | PKN2 | 1.13523050 |
| 54 | FGFR3 | 1.12737208 |
| 55 | TGFBR2 | 1.11719196 |
| 56 | FLT3 | 1.11374452 |
| 57 | ABL2 | 1.08819380 |
| 58 | JAK2 | 1.04325253 |
| 59 | PTK6 | 1.01261940 |
| 60 | MAPK7 | 1.00081795 |
| 61 | PBK | 0.99209613 |
| 62 | BRD4 | 0.98827973 |
| 63 | CASK | 0.97034042 |
| 64 | PRKG2 | 0.93811767 |
| 65 | EPHB2 | 0.93562779 |
| 66 | TAF1 | 0.93422782 |
| 67 | MAPK12 | 0.90861386 |
| 68 | PIM2 | 0.90460769 |
| 69 | MAP2K3 | 0.89747062 |
| 70 | STK39 | 0.87270304 |
| 71 | PDK1 | 0.87072521 |
| 72 | PDPK1 | 0.86536923 |
| 73 | TRIB3 | 0.85656064 |
| 74 | MST1R | 0.85554330 |
| 75 | EPHB1 | 0.79567172 |
| 76 | IRAK4 | 0.78049942 |
| 77 | PLK4 | 0.74984580 |
| 78 | NLK | 0.74431051 |
| 79 | SCYL2 | 0.73465252 |
| 80 | TIE1 | 0.73390004 |
| 81 | TGFBR1 | 0.72795336 |
| 82 | MAP2K4 | 0.72363396 |
| 83 | PNCK | 0.70814851 |
| 84 | FGR | 0.70700498 |
| 85 | VRK1 | 0.68196705 |
| 86 | IKBKE | 0.67315628 |
| 87 | MAP3K3 | 0.66488605 |
| 88 | MAP4K1 | 0.64290990 |
| 89 | MAP3K12 | 0.61752794 |
| 90 | KIT | 0.61410206 |
| 91 | CDK9 | 0.61270957 |
| 92 | MAP3K13 | 0.59687338 |
| 93 | EIF2AK2 | 0.59598508 |
| 94 | STK3 | 0.59483865 |
| 95 | NUAK1 | 0.58806238 |
| 96 | PDGFRA | 0.58166431 |
| 97 | NME1 | 0.57889252 |
| 98 | CDK19 | 0.55278673 |
| 99 | VRK2 | 0.55117052 |
| 100 | MTOR | 0.54788592 |
| 101 | FER | 0.54661108 |
| 102 | BMPR1B | 0.53166421 |
| 103 | TAOK2 | 0.52228891 |
| 104 | PRKCE | 0.51235717 |
| 105 | STK16 | 0.50922806 |
| 106 | ERBB2 | 0.49495204 |
| 107 | CSK | 0.49486719 |
| 108 | CDK4 | 0.46881315 |
| 109 | DMPK | 0.46663481 |
| 110 | CHUK | 0.45038282 |
| 111 | BRSK2 | 0.45009906 |
| 112 | ADRBK1 | 0.44466892 |
| 113 | RIPK1 | 0.43131713 |
| 114 | DAPK2 | 0.43048922 |
| 115 | KDR | 0.41950258 |
| 116 | PRKCA | 0.41811560 |
| 117 | JAK3 | 0.40828777 |
| 118 | EPHA4 | 0.40455409 |
| 119 | MET | 0.40255303 |
| 120 | TEC | 0.40200584 |
| 121 | DYRK2 | 0.39116056 |
| 122 | PRKG1 | 0.38390395 |
| 123 | ZAK | 0.38076531 |
| 124 | MAP3K7 | 0.37848478 |
| 125 | CSNK2A1 | 0.37720953 |
| 126 | LYN | 0.37505924 |
| 127 | PRKAA1 | 0.37392077 |
| 128 | PLK3 | 0.37083136 |
| 129 | PRKCQ | 0.36465303 |
| 130 | CAMK2A | 0.36167802 |
| 131 | MAPK4 | 0.35982906 |
| 132 | PIK3CA | 0.35733064 |
| 133 | WEE1 | 0.35603026 |
| 134 | GSK3A | 0.35232732 |
| 135 | PIM1 | 0.32636219 |
| 136 | BMPR2 | 0.32604132 |
| 137 | TRIM28 | 0.32217567 |
| 138 | PKN1 | 0.31925374 |
| 139 | PRKACG | 0.31472310 |
| 140 | PRKACA | 0.30490764 |
| 141 | PRKCZ | 0.29882113 |
| 142 | TXK | 0.29562367 |
| 143 | NEK1 | 0.29404473 |
| 144 | CSNK1A1 | 0.29137309 |
| 145 | CAMK4 | 0.29115290 |
| 146 | SIK2 | 0.28445736 |
| 147 | CSF1R | 0.28158227 |
| 148 | CDK12 | 0.28033023 |
| 149 | EIF2AK3 | 0.27776685 |
| 150 | WNK3 | 0.27028776 |
| 151 | PRKCD | 0.27003307 |
| 152 | CAMK1G | 0.26904066 |
| 153 | SGK3 | 0.26890537 |
| 154 | DAPK3 | 0.26865225 |
| 155 | TBK1 | 0.25545874 |
| 156 | IGF1R | 0.25394188 |
| 157 | LATS2 | 0.24248357 |
| 158 | GRK1 | 0.23787479 |
| 159 | MAP2K2 | 0.21155908 |
| 160 | WNK4 | 0.21015029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44044070 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55029106 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37428545 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.92723846 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90536248 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86577603 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.83485793 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75059024 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.47317253 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46486742 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41076387 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39406886 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34214509 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32108800 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29691181 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.28320010 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.24505171 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11634747 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.09367656 |
| 20 | Mineral absorption_Homo sapiens_hsa04978 | 2.06267924 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03992320 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01413075 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99090910 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98091871 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98054141 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94798008 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92606541 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90766108 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90426917 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87283535 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87272391 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87209010 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83134153 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82131596 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.80712712 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.78002094 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.75731046 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71285341 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61723432 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61244557 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52178758 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50215116 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49164070 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44512462 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37051104 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36451507 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36193746 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34954388 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.30135697 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.25947808 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 1.25679683 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24873097 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.23310211 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22853488 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22267175 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19302441 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16096730 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.15919632 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10034981 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08003368 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07960159 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07252454 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06832155 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04508049 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04138426 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01048590 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99658677 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99552114 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98340412 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98183265 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97820249 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94992530 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94430621 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93114774 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92855002 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92215122 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89427794 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87854028 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85121159 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81111718 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80162022 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78746757 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77907628 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75683405 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74138469 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72765247 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.72515559 |
| 88 | Proteasome_Homo sapiens_hsa03050 | 0.66198852 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65406374 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64737932 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64634990 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61297072 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60850263 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56874387 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.55063040 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52868109 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52780572 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.52771599 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.52458096 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52415515 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49717200 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48054504 |
| 103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47100371 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44924069 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44856948 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.44585532 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43413142 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41533965 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.40042722 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39154637 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37891845 |
| 112 | Phototransduction_Homo sapiens_hsa04744 | 0.37869206 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34391972 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34202291 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33783814 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30796788 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.27981135 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26865248 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22382777 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15913640 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12114243 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11613713 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08720128 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06431640 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.05406497 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.03601089 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03320210 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1785024 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1723472 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1461683 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1297342 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | -0.1248478 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1191573 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1096611 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1074304 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1036821 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | -0.0887789 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0885427 |
| 139 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0275100 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0174090 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0066683 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0002182 |

